Goldman Sachs upgraded Bruker (BRKR) to Neutral from Sell with an unchanged price target of $60. The firm believes Bruker’s market position has improved since its initiation with a Sell rating given the company’s focused investment in high growth areas, insulating it from slower overall market growth. Despite Bruker’s improved exposure, the shares are trading at the highest discount to peers in over 10 years, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: